|
Market Closed -
Euronext Bruxelles
12:55:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.000800 EUR | +33.33% |
|
-.--% | -88.89% |
| 09-29 | Oxurion NV Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-21 | Oxurion's Axiodis Partners with KYomed on Clinical Biometrics Services | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OXURION NV | Other Biotechnology & Medical Research | +33.33% | -.--% | -88.89% | -93.85% | -100.00% | 126K |  | | |
- Stock Market
- Stocks
- OXUR Stock
- Charts Oxurion NV
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
